SUMMARY Six children are described in whom deafness followed treatment of full thickness burns with topical antibiotic spray containing neomycin. 3 children developed hypocalcaemic tetany, and were shown to have a metabolic disorder involving hypocalcaemia, hypomagnesaemia, and hypokalaemia. The dangers of treating burns with topical ototoxic and nephrotoxic antibiotics are emphasised.
Six children were found to be deaf after investigation of their hearing following treatment of burns in Swindon. 3 of these children developed a syndrome of tetany associated with metabolic imbalance during treatment. All these children were treated similarly by exposure and topical antibiotic sprays containing the nephrotoxic and ototoxic antibiotics neomycin, bacitracin, polymyxin B, and colistin (polymyxin E).
Although users of these proprietary sprays are warned of potential side effects, including deafness and renal complications, we feel that the dangers of their topical use on burned surfaces are not sufficiently realised.
Case reports Case 1. A boy of 16 months sustained scalds to 10% of his body surface. On day 32 of admission he developed tetany. Investigations at that time showed normal plasma sodium and albumin, but low potassium 2 -88 mmol/l (mEq/l), calcium 1 * 75 mmol/l (7 mg/100 ml), magnesium 0 35 mmol/l (0 85 mg/100 ml), chloride 91 2 mmol/l (mEq/l), and a raised blood urea 16 mmol/l (96 mg/100 ml). He Topical antibiotics were applied 4-hourly by nursing staff, while unhealed and nongrafted surfaces were exposed (usually 3 weeks). No record was made of the amount of spray used, but it was reported to be up to one full container per day. For all but the most recent case (Case 3) the antibiotic was Disbiotic (Avlex). This contains neomycin sulphate 500 000 U (735 g), colistin (polymyxin E) 300 000 U, zinc bacitracin 37 000 U. In Case 3, the antibiotic was Dispray (Avlex): neomycin sulphate 650 000 U The nephrotoxic and ototoxic effects of neomycin are well described (Meuwisson and Robinson, 1967; British Medical Journal, 1969; Vinnicombe and Stamey, 1969; Appel and New, 1977) . Polymyxin is known to be nephrotoxic (Jawetz, 1961; Vinnicombe and Stamey, 1969; Appel and New 1977) , and colistin shares the toxic effects of the polymyxins, being indistinguishable from polymyxin E. Colistin has been said to cause partial deafness at very high plasma levels (Meuwissen and Robinson, 1967 ) but this has not been commonly reported. Experimentally, polymyxin B has caused cochlear damage in guinea pigs (Kohonen and Tarkkanen, 1961) . Topically the polymyxins are said not to be absorbed (Vinnicombe and Stamey, 1966) , but if given parenterally have been incriminated in a syndrome of hyponatraemia, hypokalaemia, hypochloraemia, and hypocalcaemia (Rodriguez et al., 1970) as well as in reduced glomerular filtration rate, and azotaemia. Bacitracin is known to be nephrotoxic, causing azotaemia when given parenterally, but is not absorbed when applied topically (Jawetz, 1961) .
Neomycin administered orally has been shown to have nephrotoxic and ototoxic effects in certain conditions in adults, in hepatic failure (Last and Sherlock, 1960) and after laparotomy (Greenberg and Momary, 1965; Ruben and Daly, 1968) , and audiotoxic effects in children (Zelenka et al., 1966) . Similarly ototoxic effects have been reported after rectal irrigation (Fields, 1964) and wound irrigation (Kelly et al., 1969) .
Topically, neomycin has been incriminated in ototoxicity when absorption was aided by dimethylsulphoxide (Herd et al., 1967) in a 6-year-old girl, and inhalation by aerosol has been shown to cause hearing loss in children (Fuller, 1960) . Parenteral administration has been well documented as a cause of acute tubular necrosis and subsequent deafness (De Beauklaer et al., 1971) and there has been a previous report of topical neomycin contained in bacitracin and polymyxin (Polybactrin) spray causing deafness in a severely burned (80 %) 5-yearold child (Stewart, 1966) . Typically, deafness has been progressive and irreversible, starting with a high tone loss. Presentation may be delayed for some months after exposure to the neomycin (Meuwissen and Robinson, 1967; Herd, 1967; Kelly et al., 1969) .
The syndrome of hypokalaemia, hypomagnesaemia, and hypochloraemic alkalosis has been described in adults on gentamicin therapy for pulmonary tuberculosis by Holmes et al. (1970) . They found raised aldosterone levels in their patients, and ascribed this to a hyperaldosteronism consequent on the antibiotic. 2 further adult patients were described by Bar et al. (1975) who developed hypomagnesaemia and hypocalcaemia on high dose gentamicin therapy. There was high urinary magnesium and potassium loss and low parathormone levels. Gentamicin-induced magnesuria and kaluria was suggested as the initial problem with a consequent hypomagnesaemia, hypocalcaemia, and hypokalaemia. In these cases the aldosterone levels were normal. The biochemical abnormalities were slow to resolve (8 and 15 weeks respectively).
The biochemical findings in our patients were similar to those in the gentamicin patients, and, of the antibiotics present in the antibiotic sprays, neomycin is similarly an aminoglycoside. Urinary potassium loss was raised in Case 3 and was likely to be so in the face of low plasma potassium levels in Case 2. Case 3 was the only patient in whom urinary magnesium loss was measured, the loss probably being excessive as magnesuria usually stops in the face of hypomagnesaemia. Calcium loss was normal in Case 3. In all patients the abnormalities were slow to resolve, and were refractory to initial calcium replacement, all requiring magnesium replacement. The mechanism remains obscure, but is most simply explained by an interference in renal magnesium and potassium reabsorption, with the hypocalcaemia resulting from the hypomagnesaemia.
The delay in diagnosing deafness may well have been due to the delayed and progressive nature of the lesion. There is strong supporting evidence in Case 3 where hearing was followed up prospectively. Speech upsets may be easily explained immediately after a prolonged and painful hospital stay, particularly at such a sensitive period of speech development. However, the prolonged delay in speech eventually alerted parents to the possibility of deafness.
There is still doubt as to why these particular patients suffered such complications, although other children were treated similarly between 1965 and 1976. Age at burn (8-16 months) may have been critical, being the earliest age at which significant burns are likely in the exploring toddler. All affected infants were boys. Over the period where complete records are available , boys outnumbered girls in hospital admissions for burns by 37 to 23.
The surface area of the scalds was considerable (10-22%,) and all had full thickness burns. 
